Drugs / colimycin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01060891 | May 2009 → Apr 2015 | gram-negative bacterial infections | Poitiers University Hospital | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02906722 Comparator | Jul 2017 → Mar 2018 | — | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | colimycin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02906722 ↗ |
| Route | Intravenous | “intravenous colimycin administered once, twice or 3 times per day according to function renal” NCT02906722 ↗ |